Health and Fitness Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug by Press on December 1, 2015 Press Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 18-Month Investigation Reveals a Pricing and Marketing Strategy Designed to Maximize Revenue with Little Concern for Access or Affordability